0001437749-23-004948.txt : 20230228 0001437749-23-004948.hdr.sgml : 20230228 20230228172353 ACCESSION NUMBER: 0001437749-23-004948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230224 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olwill Shane CENTRAL INDEX KEY: 0001875416 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37471 FILM NUMBER: 23687499 MAIL ADDRESS: STREET 1: C/O PIERIS PHARMACEUTICALS, INC. STREET 2: 255 STATE STREET, 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001583648 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300784346 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-246-8998 MAIL ADDRESS: STREET 1: 225 FRANKLIN STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: Marika Inc. DATE OF NAME CHANGE: 20130805 4 1 rdgdoc.xml 230228 FORM 4 (OLWILL) X0306 4 2023-02-24 0001583648 PIERIS PHARMACEUTICALS, INC. PIRS 0001875416 Olwill Shane C/O PIERIS PHARMACEUTICALS, INC. 225 FRANKLIN STREET, 26TH FLOOR BOSTON MA 02110 1 Chief Development Officer Stock Option (Right to buy) 1.39 2023-02-24 4 A 0 249080 0 A 2033-02-24 Common Stock 249080 249080 D The option vests as to 25% of the option shares on February 24, 2024 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter. /s/ Ahmed Mousa, Attorney-in-fact 2023-02-28